TYRP1 and melanoma: Thus, rVSV expressing the human interferonbeta (IFN-β) gene and rVSV expressing two supplementary genes (theIFN-β gene and the TYRP1 gene thatencodes tyrosinaserelated protein 1 and is expressed in melanocytes), arecurrently in phase I clinical trials aiming to assess treatment ofhepatocellular carcinoma (NCT01628640) and stage III/IV melanoma (NCT03865212),respectively.